Browsing Topic

biotech

9 posts
The Market Online Video

Memphasys tech: Trial results prove it lifts the guys’ game in IVF

Memphasys reproductive technology is proving a gamechanger in the guys' side of infertility – which is…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Map showing Valeriepieris Circle - a relatively small area of Earth’s surface that contains half the human population.

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical…
  • 4 mins
  • 02 October 2024 07:15 (AEST)
Image of nerve cells with antibodies.

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Noxopharm Ltd is planning the first human trial to assess novel drug SOF-SKN, which aims to…
Image of DNA structure.

Genetic Tech boosts reach of the geneType risk tests in 42 countries with global launch

Genetic Technologies Ltd has announced the global launch of its geneType risk tests on the EasyDNA…

Telix kicks off $300M NASDAQ IPO offer, backed by Morgan Stanley

Morgan Stanley and Jefferies are among the managers overseeing Telix Pharma's (ASX:TLX) freshly commenced US IPO…
  • 1 min
  • 06 June 2024 09:59 (AEST)

Cleo Diagnostics reports its ovarian cancer blood tests superior to ultrasound

Nine moths after listing on the ASX, Cleo Diagnostics (ASX:COV) has made its first major biotech breakthrough.
  • 2 mins
  • 29 May 2024 10:36 (AEST)
The Market Online Video

Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market

Pharmaceutical companies can bring new hope to patients by delivering solutions to unmet medical needs. They…

Brokers meet Biotech – four Aussie companies driving medtech solutions

Biotech tends to follow a four to five year market cycle and those in the sector say there are signals that the next